CIDRAP newsletters options
Cases are falling in Cleveland; Newark, New Jersey; Washington, DC; and New York state.
After battling foreign fluctuations, Nexus Pharmaceuticals bucks convention and builds local.
A randomized clinical trial found that fosfomycin did not demonstrate noninferiority to comparator antibiotics for bacteremic urinary tract infections (bUTIs) caused by multidrug-resistant (MDR) Escherichia coli, but it could remain an option for select patients, researchers reported yesterday in JAMA Network Open.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Needless insurer spending on ivermectin prescriptions for COVID-19, estimated at $2.5 million in the United States for the week of Aug 13, 2021—the most recent week analyzed—would extrapolate to $130 million annually, US researchers reported yesterday in JAMA.
The Court allowed a mandate for workers at federally funded healthcare facilities.
Yet 80% of low-risk newborns got antibiotics, and for similar durations as high-risk infants.
India's cases have spiked 30-fold in a month, fueled by the highly transmissible Omicron variant.
In 1 of the 3 studies, vaccination was 98% protective against ICU stay and life support in teens.
Austrian scientists writing in a letter in the New England Journal of Medicine yesterday demonstrate poor neutralization of the Omicron variant when using serum from vaccinated or recovered COVID-19 patients, potentially signaling a need for variant-specific vaccines.
Danish microbiome technology company SNIPR Biome ApS announced this week that the US Food and Drug Administration has approved the company's application to initiate the first human clinical trial of its CRISPR-based drug for preventing Escherichia coli infections in cancer patients.
Risk factors were older age, chronic conditions, and longer symptoms.
"Almost 50,000 deaths a week is 50,000 deaths too many," says WHO head.
The steps are part of continued efforts to keep schools open for in-person learning.
The US COVID-19 vaccination program may have averted 14 million infections, saved more than 240,000 lives, and prevented upwards of 1.1 million hospitalizations in the first half of 2021, according to estimates from a modeling study yesterday in JAMA Network Open.
A study of 42 million US patient visits for antibiotic-inappropriate acute respiratory infections (ARIs) found that more than 10% received an antibiotic prescription, with providers in urgent care clinics and southern states among the most likely prescribers, US researchers reported this week in Infection Control & Hospital Epidemiology.
Those who got a third dose had 12.8 cases per 100,000 person-days, vs 116 in the unboosted.
Yesterday the US reported 1.35 million new COVID-19 cases, the most any nation has ever reported in 1 day.
New data show the Omicron variant spreads more easily by asymptomatic people.
US Federally qualified health centers (FQHCs) have been critical to providing COVID-19 vaccinations to low-income and racial minority populations, finds a study yesterday in JAMA Network Open.
